LBA
CVS icon

Letko, Brosseau & Associates’s CVS Health CVS Stock Holding History

Letko, Brosseau & Associates’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$80.1M Buy
1,114,735
+2,875
+0.3% +$221K 1.29% 31
2025
Q4 		$88.2M Sell
1,111,860
-3,725
-0.3% -$294K 1.44% 24
2025
Q3 		$84.1M Buy
1,115,585
+3,500
+0.3% +$240K 1.44% 23
2025
Q2 		$76.7M Sell
1,112,085
-105
-0% -$6.88K 1.47% 26
2025
Q1 		$75.4M Sell
1,112,190
-2,470
-0.2% -$148K 1.6% 23
2024
Q4 		$50M Buy
1,114,660
+27,180
+2% +$1.52M 0.97% 43
2024
Q3 		$68.4M Buy
1,087,480
+50,215
+5% +$2.93M 1.24% 33
2024
Q2 		$61.3M Buy
1,037,265
+278,110
+37% +$17.4M 1.16% 39
2024
Q1 		$60.6M Sell
759,155
-1,685
-0.2% -$129K 1.05% 37
2023
Q4 		$60.1M Sell
760,840
-10,270
-1% -$731K 1.09% 34
2023
Q3 		$53.8M Buy
771,110
+254,900
+49% +$18.1M 1.05% 37
2023
Q2 		$35.7M Buy
516,210
+10,925
+2% +$777K 0.66% 55
2023
Q1 		$37.5M Buy
505,285
+110,035
+28% +$9.23M 0.7% 52
2022
Q4 		$36.8M Sell
395,250
-880
-0.2% -$84.9K 0.66% 58
2022
Q3 		$37.8M Sell
396,130
-9,500
-2% -$940K 0.75% 50
2022
Q2 		$37.6M Sell
405,630
-5,690
-1% -$555K 0.67% 52
2022
Q1 		$41.6M Sell
411,320
-12,655
-3% -$1.33M 0.62% 55
2021
Q4 		$43.7M Sell
423,975
-13,500
-3% -$1.25M 0.63% 53
2021
Q3 		$37.1M Sell
437,475
-27,275
-6% -$2.28M 0.54% 54
2021
Q2 		$38.8M Sell
464,750
-7,600
-2% -$622K 0.52% 59
2021
Q1 		$35.5M Sell
472,350
-20,500
-4% -$1.49M 0.48% 58
2020
Q4 		$33.7M Buy
+492,850
New +$32.1M 0.46% 60

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Letko, Brosseau & Associates's CVS Position: Q1 2026 in Review

Letko, Brosseau & Associates increased its CVS Health (CVS) stake by 0.26% in Q1 2026, buying an estimated $221K and bringing the position to 1,114,735 shares worth $80.1M. The position accounts for 1.29% of the portfolio, ranked #31.

Letko, Brosseau & Associates first reported a position in CVS in Q4 2020 and has held it in 22 quarters since. The position peaked at $88.2M in Q4 2025. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Letko, Brosseau & Associates held 1,114,735 shares of CVS Health worth $80.1M as of Q1 2026.
  • Letko, Brosseau & Associates bought 2,875 CVS Health shares in Q1 2026, an estimated $221K.
  • CVS Health made up 1.29% of Letko, Brosseau & Associates's portfolio in Q1 2026, its #31 holding.
  • Letko, Brosseau & Associates first reported a position in CVS Health in Q4 2020 and has held it in 22 quarters since.
  • Letko, Brosseau & Associates's CVS Health position peaked at $88.2M in Q4 2025.
  • 1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Letko, Brosseau & Associates's 13F filing for Q1 2026, filed 12 May 2026.